TRIVAROP

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
>
Registration as it was on 08 Feb 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

37,500€

Financial year: Jan 2015 - Dec 2015

Lobbyists (Full time equivalent)

0.5 Fte (1)

Lobbyists with EP accreditation

1

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    TRIVAROP   (TRIVAROP)

    EU Transparency Register

    78758165752-12 First registered on 28 Apr 2011

    Goals / Remit

    Trivarop is specialised biotechnology and vaccines particularly those fields related with innovation, international relations, development and Sustainable Development Goals, sanitary prevention,vaccination,zoonoses, one health policies and humanitarian aid.

    In addition to its expertise in biotechnology and the value chain of vaccinology and innovation, TRIVAROP also assists organisations in management and interim-management, more specifically to elaborate strategic plans, public relation strategies, and can temporarely assume direction duties on an interim basis.

    Trivarop particularly focuses on EU Innovation Union, EU 2020 and innovative solutions in Health, biotechnology with positive impact on added value creation.

    Main EU files targeted

    New legislation on Animal Health, New legislation on Veterinary medicines, Clinical trials in human and animal health, EBOLA, ZIKA, transborder sanitary and pandemic threats, antimicrobial resistance, zoonoses and zoonoses control, control and prevention of bioterrorism, pandemic preparedness,
    Economic Partnership agreements

    Address

    Head Office
    de la Tannerie, 14
    COLFONTAINE 7340
    BELGIUM
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    50%1

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    1 accreditations were / are live (in bold) for the selected state of 08 Feb 2017

    Name Start date End Date
    Mr Joris VANDEPUTTE 17 Nov 2020 17 Nov 2021
    Mr Joris VANDEPUTTE 13 Nov 2019 13 Nov 2020
    Mr Joris VANDEPUTTE 15 Nov 2018 13 Nov 2019
    Mr Joris VANDEPUTTE 28 Nov 2017 14 Nov 2018
    Mr Joris VANDEPUTTE 15 Nov 2016 12 Nov 2017
    Mr Joris VANDEPUTTE 17 Nov 2015 12 Nov 2016
    Mr Joris VANDEPUTTE 11 Nov 2014 10 Nov 2015
    Mr Joris VANDEPUTTE 08 Nov 2013 07 Nov 2014
    Mr Joris VANDEPUTTE 22 Nov 2012 08 Nov 2013
    Mr Joris VANDEPUTTE 18 Jan 2012 08 Feb 2013

    Complementary Information

    None declared

    Person in charge of EU relations

    Mr Joris Vandeputte (Président)

    Person with legal responsibility

    Mr Joris Vandeputte (Président)

  • Categories

    Category

    I - Professional consultancies/law firms/self-employed consultants

    Subcategory

    Professional consultancies

  • Networking

    Affiliation

    CEPS
    European TB coalition
    Parliamentary working group on Innovation, Access to Medicines and Poverty-Related Diseases
    IABS (International Alliance for Biological Standardisation)
    Mazungumzo, the African Forum in Brussels
    Civil society on poverty related diseases

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2015 - Dec 2015

    Lobbying costs for closed financial year

    37,500€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    Global Health Forum
    None

    ACC

    None

    Groups (European Parliament)

    The European Parliament Working Group on innovation, access to medicines and poverty-related diseases

    Communication activities

    Projects: discussions and input on the medicines, animal health, veterinary medicines proposals
    Cotonou agreements
    HORIZON 2020, IMI
    Events: organisation of symposia in particular with International Organisations and the International Alliance for Biological Standardization (IABS)

    Other activities

    Previous activities with relation to transparency register:
    - Development of new vaccines against tuberculosis and other poverty related diseases in human and animal health, set up innovative ways of funding to translate EU discoveries into innovative globally accessible vaccines.
    - Advocacy for support to invest in new tools, vaccines and treatments, to fight Tuberculosis and other poverty related diseases
    - GALVmed: development of animal health vaccines against neglected diseases that cost at least 20 % loss to food production in developing countries- VACNADA
    - Health logistics, Bioforce
    Present activities in relation with transparency register:
    - EU 2020, competitive Europe
    - World Organisation for Animal Health (OIE Office International des Epizooties): one health policies, zoonoses, early warnings for pandemics in humans and epidemics in animals
    - The International Alliance for Biological Standardisation (IABS and IABS-EU)
    - Mazungumzo think thank, the African Forum in Brussels

  • Meetings

    Meetings

    None declared

Download this datacard